Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02530073 · ClinicalTrials.gov registry record · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
A NA study of Congenital Diaphragmatic Hernias, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02530073: Recruiting NA study of Congenital Diaphragmatic Hernias, sponsored by Connecticut Children's Medical Center.
NCT02530073 is a NA study of Congenital Diaphragmatic Hernias that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02530073, a NA study of Congenital Diaphragmatic Hernias, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
Primary Outcome
Feasibility, safety, and survival rates of the FETO procedure
Conditions Studied
Interventions
- DEVICE Fetoscopic Endoluminal Tracheal Occlusion (FETO)
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-09 |
| Est. Completion | 2030-08 |
| Phase | NA |
What NCT02530073 shows while recruiting
NCT02530073 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Congenital Diaphragmatic Hernias appearing as the primary indexed condition, and to 1 intervention - of which Fetoscopic Endoluminal Tracheal Occlusion (FETO) is the first listed.
NCT02530073 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02530073 about?
NCT02530073 is a clinical study titled "Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH". The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
What is the current status of trial NCT02530073?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2015-09. Estimated completion is 2030-08.
What conditions does trial NCT02530073 study?
This clinical trial studies the following conditions: Congenital Diaphragmatic Hernias.
What interventions are being tested in trial NCT02530073?
The interventions under investigation include: Fetoscopic Endoluminal Tracheal Occlusion (FETO) (DEVICE).
Who is sponsoring clinical trial NCT02530073?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02530073 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02530073's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
- NCT02977468 · 15 participants · Phase 1
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia